Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Breast Neoplasms 51 Neoplasms 36 Lung Neoplasms 24 Colorectal Neoplasms 24 Prostatic Neoplasms 15 Uterine Cervical Neoplasms 14 Motor Activity 13 Colonic Neoplasms 11 Rectal Neoplasms 9 Hematologic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Anxiety Disorders 9 Pancreatic Neoplasms 8 Obesity 8 Lymphoma 8 Depression 8 Endometrial Neoplasms 7 Vulvar Neoplasms 6 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Melanoma 6 Head and Neck Neoplasms 6 Breast Carcinoma In Situ 6 Pain 5 Neoplasm Metastasis 5 Leukemia, Myeloid, Acute 5 Hematopoietic and Lymphatic System Neoplasm 5 Triple Negative Breast Neoplasms 4 Smoking Cessation 4 Papillomavirus Infections 4

Interventions

Dexamethasone 4 XENP 1595 2 Electroencephalography 2 selinexor 1 pomalidomide 1 ixazomib 1 fasudil 1 birtamimab 1 UE2343 1 Telemedicine 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Methods 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Donepezil 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Alzheimer Disease × Methods × Clear all

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡